Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment. - Wikidata - wikimedia - TriplyDB

Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment.

Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment.

http://www.wikidata.org/entity/Q33260828

about

Bevacizumab versus ranibizumab for neovascular age-related macular degeneration: a Meta-analysis.Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration.Therapeutic antibodies in ophthalmology: old is new again.Retinal pigment epithelial detachments in age-related macular degeneration: classification and therapeutic options.High Dose Intravitreal Bevacizumab for Refractory Pigment Epithelial Detachment in Age-related Macular Degeneration.Two-year course of subfoveal pigment epithelial detachment in eyes with age-related macular degeneration and visual acuity better than 20/40.

P2860

Q35075402-97A36A33-3D1B-43A7-9A54-5BA8BF997EB1 Q37684468-544D6A57-136B-46AA-807F-BFC980D27B1E Q37848065-350A6B1A-D529-4584-B7A1-C875C0BBCF1A Q37879178-CD5BEAF5-FB24-4B15-A799-FB0BC330F86C Q42236754-D3E92FF2-F530-4781-83B7-881DE6968F65 Q50498980-03D794B4-1BEA-41F3-A757-23F980F7598C

P2860

Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment.

http://www.wikidata.org/entity/Q33260828

description

2006 nî lūn-bûn

@nan

2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment.

@ast

Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment.

@en

Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment.

@nl

type

label

Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment.

@ast

Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment.

@en

Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment.

@nl

prefLabel

Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment.

@ast

Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment.

@en

Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment.

@nl

P1433

Q33260828-37EB5FC1-AE95-4E5C-A114-784460F5AE9D

P1476

Q33260828-8B3B2832-232F-424F-8F85-3AAF727DA031

P2093

Q33260828-41B72A55-A140-4F4A-A19A-F892C6224827

Q33260828-7F3BF1EB-B1F1-4C68-8B93-BB338CCFF318

Q33260828-D89F9049-722E-4CA8-9993-5898535245F9

Q33260828-F6FAEA57-E0EF-4702-ACD0-BA4012C6126B

P2860

Q33260828-004C059F-840E-4C82-8DDA-E1A80A7FC7AD

Q33260828-051E67CE-59D6-4BD6-98C4-ADA1CEB376E9

Q33260828-05B13158-4BD4-4ABF-95EC-A564A6052528

Q33260828-12F2399F-9DC0-4686-BF92-EE2C8A598815

Q33260828-16BDE8A2-269B-4505-9C64-C27F6D40FF2A

Q33260828-16D65AF2-86E3-4A07-A3C0-996C86710439

Q33260828-29A13E53-CD41-4750-B958-8427072A5993

Q33260828-3069C59B-8CE2-4B37-9244-009871C02FDF

Q33260828-359C312C-FB9A-4569-B678-119A2F51F6B1

Q33260828-4F799F08-5A65-4C74-B858-C3067FC6C39C

P304

Q33260828-93262443-F962-4DC0-BE1A-8B222E5A2C96

P31

Q33260828-CC2D867D-3B85-4955-A094-E86ADB15E0DC

P356

Q33260828-03C0CD4B-58EF-4771-84C6-2FE556D261BC

P407

Q33260828-355CACB4-49A5-4C86-B719-A5F0E29D2D05

P433

Q33260828-25C3D05C-DFF5-4029-8C90-6B18368A0076

P478

Q33260828-1FF571E0-876F-4D09-B9BD-FA92C8EB2C24

P50

Q33260828-2E451D08-4ED4-46E8-8FE1-36C43EFA75E3

P577

Q33260828-9E490C4F-7231-485A-8443-D6169D9E8993

P5875

Q33260828-193AFAA5-65D8-4789-86FE-B7123197D7CA

P698

Q33260828-781A51F7-D3B8-44BA-8FE3-D5BA85147252

P921

Q33260828-F1541225-3848-4649-A7FA-EE4DA17348EE

P932

Q33260828-FE1831C3-60FF-4AD9-A5CC-4D9F696F647E

P356

BJO.2006.102467

P1433

British Journal of Ophthalmology

P1476

Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment.

@en

P2093

Franz Prager

http://www.w3.org/2001/XMLSchema#string

Matthias Bolz

http://www.w3.org/2001/XMLSchema#string

Stephan Michels

http://www.w3.org/2001/XMLSchema#string

Wolfgang Geitzenauer

http://www.w3.org/2001/XMLSchema#string

P2860

Age-related eye diseases: an emerging challenge for public health professionals

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Treatment of pigment epithelial detachments due to age-related macular degeneration with intra-ocular C3F8 injection.

Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.

Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes.

Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer.

Vascular endothelial growth factor: basic science and clinical progress.

Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11.

The epidemiology of age-related macular degeneration.

Photodynamic therapy for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration.

P304

785-789

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BJO.2006.102467

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P50

Ursula Schmidt-Erfurth

P577

2006-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6744382

http://www.w3.org/2001/XMLSchema#string

P698

17050580

http://www.w3.org/2001/XMLSchema#string

P921

P932

2266832

http://www.w3.org/2001/XMLSchema#string